There is real hope, thanks to legislation expected by the end of the year and the public discussion of drug safety that has occurred since Merck 's (nyse: MRK - news - people ) Vioxx, that the FDA is going to getbetter at tracking the long-term safety of the pills millions of people swallow everyday.